genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Electroporation

Overcoming Viral Vector Risks
Bioprocessing

Overcoming Viral Vector Risks

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies
News

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
GEN Edge

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough

Improving Flow through the Cell Therapies Bottleneck
Bioprocessing

Improving Flow through the Cell Therapies Bottleneck

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs
Genome Editing

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs

Low-Cost, Single-Cell Electroporation
Bioprocessing

Low-Cost, Single-Cell Electroporation

Case Study: Genetic Engineering of Adoptive Cell Therapies
Drug Discovery

Case Study: Genetic Engineering of Adoptive Cell Therapies

MaxCyte Signs B Cell Platform Agreement with Walking Fish Therapeutics
Cancer

MaxCyte Signs B Cell Platform Agreement with Walking Fish Therapeutics

CAR-T Sector Seeks Tech Boost to Meet Anticipated Demand
Bioprocessing

CAR-T Sector Seeks Tech Boost to Meet Anticipated Demand

Electroporation-Mediated Designer T-Cells for Immunotherapy and Immunoassays
Insights

Electroporation-Mediated Designer T-Cells for Immunotherapy and Immunoassays

123Page 1 of 3

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up